In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $12.06 in the prior trading day, Sotera Health Co (NASDAQ: SHC) closed at $11.75, down -2.57%. In other words, the price has decreased by -$2.57 from its previous closing price. On the day, 1.19 million shares were traded.
Ratios:
Our goal is to gain a better understanding of SHC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.12. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 2.46. In the meantime, Its Debt-to-Equity ratio is 5.67 whereas as Long-Term Debt/Eq ratio is at 5.61.
On December 06, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $14.
On May 21, 2024, Piper Sandler started tracking the stock assigning a Neutral rating and target price of $13.Piper Sandler initiated its Neutral rating on May 21, 2024, with a $13 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 06 ’24 when WARBURG PINCUS & CO. sold 15,000,000 shares for $15.03 per share. The transaction valued at 225,450,000 led to the insider holds 73,822,952 shares of the business.
WARBURG PINCUS & CO. sold 15,000,000 shares of SHC for $225,450,000 on Sep 06 ’24. The Director now owns 73,822,952 shares after completing the transaction at $15.03 per share. On Sep 06 ’24, another insider, GTCR INVESTMENT XI LLC, who serves as the Director of the company, sold 10,000,000 shares for $15.03 each. As a result, the insider received 150,300,000 and left with 49,215,301 shares of the company.
Valuation Measures:
As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 135.68, and their Forward P/E ratio for the next fiscal year is 13.81. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 12.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.01 while its Price-to-Book (P/B) ratio in mrq is 8.05.
Stock Price History:
Over the past 52 weeks, SHC has reached a high of $17.08, while it has fallen to a 52-week low of $9.53. The 50-Day Moving Average of the stock is -0.71%, while the 200-Day Moving Average is calculated to be -13.25%.
Shares Statistics:
A total of 283.86M shares are outstanding, with a floating share count of 146.62M. Insiders hold about 48.35% of the company’s shares, while institutions hold 49.95% stake in the company.
Earnings Estimates
At present, 7.0 analysts are actively evaluating the performance of Sotera Health Co (SHC) in the stock market.The consensus estimate for the next quarter is $0.2, with high estimates of $0.21 and low estimates of $0.2.
Analysts are recommending an EPS of between $0.78 and $0.74 for the fiscal current year, implying an average EPS of $0.75. EPS for the following year is $0.85, with 7.0 analysts recommending between $0.89 and $0.82.
Revenue Estimates
6 analysts predict $275.81M in revenue for the current quarter. It ranges from a high estimate of $277M to a low estimate of $274.34M. As of the current estimate, Sotera Health Co’s year-ago sales were $276.59MFor the next quarter, 6 analysts are estimating revenue of $297.73M. There is a high estimate of $300.36M for the next quarter, whereas the lowest estimate is $294.57M.
A total of 6 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.15B, while the lowest revenue estimate was $1.13B, resulting in an average revenue estimate of $1.14B. In the same quarter a year ago, actual revenue was $1.1BBased on 6 analysts’ estimates, the company’s revenue will be $1.21B in the next fiscal year. The high estimate is $1.22B and the low estimate is $1.2B.
